Uncategorized

Harley-Davidson X350 Patent Revealed in India

In an exciting development for motorcycle enthusiasts, the patent for the Harley-Davidson X350 has surfaced in India, sparking widespread speculation about the potential launch of the entry-level roadster in the domestic market. Developed in collaboration with Chinese partner Qianjiang Motor, the X350 is Harley-Davidson’s strategic attempt to expand its footprint in the small-displacement motorcycle segment […]

Uncategorized

OmniActive Sues Bio‑Gen for Patent Infringement Over Eye Health Ingredients

OmniActive Health Technologies, a leading global supplier of clinically studied health and wellness ingredients, has filed a patent infringement lawsuit against Indian nutraceutical firm Bio‑Gen Extracts Pvt. Ltd. in the U.S. District Court for the Eastern District of Texas. The lawsuit centers on U.S. Patent No. 10,532,035, owned by OmniActive, which protects a proprietary formulation

Uncategorized

India Limits TB Drug Sales to Government Health Systems

The Drugs Controller General of India (DCGI) has limited the sale of key TB drugs—bedaquiline, delamanid, pretomanid, and rifapentine—exclusively to government healthcare systems under the NTEP to combat rising drug-resistant TB cases. In a significant move to curb the growing threat of drug-resistant tuberculosis (TB), the Drugs Controller General of India (DCGI) has issued a

AI, Trademark

OpenAI Erases ‘io’ Branding After Trademark Clash with AI Startup IYO

OpenAI has removed all public references to “io” — the hardware startup co-founded by legendary Apple designer Sir Jony Ive — following a U.S. federal court’s temporary restraining order arising from a trademark infringement complaint filed by rival company IYO. The development marks a significant legal hurdle for OpenAI’s ambitious hardware expansion and raises key

Uncategorized

Dr. Reddy’s Challenges Novo Nordisk’s Ozempic Patent in India, Paving Way for Cheaper Weight Loss Drugs

Indian pharmaceutical major Dr. Reddy’s Laboratories has mounted a significant legal challenge against Novo Nordisk’s patent for semaglutide, the key ingredient in its blockbuster weight-loss and diabetes drug Ozempic, potentially opening the door for affordable generics in India and other emerging markets. Filed in the Delhi High Court, the challenge targets Novo’s secondary patent on

Uncategorized

Delhi High Court Stops Use of Deceptive “Domino’s” Variants in Trademark Dispute – Interim Relief for Domino’s Pizza

The Delhi High Court has granted interim relief to Domino’s IP Holder LLC and Jubilant FoodWorks Limited, restraining several businesses from using deceptively similar names to the globally recognized “Domino’s” trademark. The court passed the order in response to a trademark infringement lawsuit filed by Domino’s against fifteen different entities operating under names such as

Scroll to Top